> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest FDA Warning Letters
- URL: https://www.fdaweb.com/latest-fda-warning-letters-51/
- Published: 2021-01-26T12:00:00.000Z
- Updated: 2026-09-14T16:44:03.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5148531

FDA has posted its latest batch of Warning Letters. They can be accessed by clicking on the link following each letter.

**Sage Moon Apothecary**, Seal Harbor, ME (1/14): FDA has reviewed the company’s Web sites and determined that its products “Golden Milk Electuary-Mushroom Cocoa Blend,” “Golden Milk Electuary,” and “Beyond Elderberry Syrup” are new drugs based on the claims being made. The products are also considered misbranded because they fail to bear adequate directions for use. The agency told the company to promptly take action to correct the violations cited in the letter. To view the letter, click [here](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sage-moon-apothecary-llc-611376-01142021?ref=fdaweb.com).

**Yuyao Yijia Daily Chemical Co.**, Ningbo, China (1/22): An FDA review of records and other information submitted by the over-the-counter drug product manufacturer identified significant GMP violations for finished pharmaceuticals. For example, the company failed to have for each batch of drug product appropriate laboratory determination of satisfactory conformance to final specifications. It also failed to conduct at least one test to verify the identity of each component of a drug product. To view the letter, click [here](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/yuyao-yijia-daily-chemical-co-ltd-610487-01222021?ref=fdaweb.com).